Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine - J Morganroth - Libros - Springer-Verlag New York Inc. - 9781461288886 - 10 de octubre de 2011
En caso de que portada y título no coincidan, el título será el correcto

Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine Softcover reprint of the original 1st ed. 1989 edition

Precio
$ 204,49
sin IVA

Pedido desde almacén remoto

Entrega prevista 19 de jun. - 1 de jul.
Añadir a tu lista de deseos de iMusic

The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.


298 pages, biography

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 10 de octubre de 2011
ISBN13 9781461288886
Editores Springer-Verlag New York Inc.
Páginas 298
Dimensiones 234 × 154 × 23 mm   ·   490 g
Lengua Inglés  
Editor Moore, E. Neil
Editor Morganroth, J.

Mas por J Morganroth

Mostrar todo

Mere med samme udgiver